Company chart and information is provided by TradingView based on 15-minute-delayed data.
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates.
| Website: | www.zealandpharma.com |
| Email: | info@zealandpharma.com |
| Main Phone: | +45 88773600 |
| Address: | Sydmarken 11 |
| Address 2: | Glostrup |
| City / Town: | Soborg |
| Country: | DK |
| Postal Code: | DK-2860 |
| Exchange: | NGS |
| CEO: | Emmanuel Dulac |
| Employees: | 626 |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
